Clinical Trial: A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938529) titled 'A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function' on April 14.

Brief Summary: This is an open-label, non-randomized study to assess how VCT220 is absorbed, distributed, metabolized, and eliminated after a single oral dose. The study includes three groups: subjects with mild hepatic impairment (Child-Pugh Class A), subjects with moderate hepatic impairment (Child-Pugh Class B), and healthy subjects matched by gender, age, and body mass index (BMI). It will also explore the relationship between baseline liver function measures and the pharmacokinetic (PK) parameters of VCT220, to suppo...